Search


Current filters:
Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 10 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2012The interaction between the maternal BMI and angiogenic gene polymorphisms associates with the risk of spontaneous preterm birthAndraweera, P.; Dekker, G.; Thompson, S.; North, R.; McCowan, L.; Roberts, C.
2012Prevalence of polycystic ovary syndrome in a sample of Indigenous women in Darwin, AustraliaBoyle, J.; Cunningham, J.; O'Dea, K.; Dunbar, T.; Norman, R.
2012PCOS and thromboembolism: a complex caseReid, S.; Norman, R.
2012Does ovulation induction with follicle-stimulating hormone still have a future in polycystic ovary syndrome?Norman, R.
2012The effect of bariatric surgery on female reproductive functionMoran, L.; Norman, R.
2012Polycystic ovary syndrome: what do the new guidelines recommend?Joham, A.; Teede, H.; Norman, R.
2012Metformin versus clomiphene citrate for infertility in non-obese women with polycystic ovary syndrome: a systematic review and meta-analysisMisso, M.; Costello, M.; Garrubba, M.; Wong, J.; Hart, R.; Rombauts, L.; Melder, A.; Norman, R.; Teede, H.
2011Association of vascular endothelial growth factor +936 C/T single-nucleotide polymorphism with pregnancies complicated by small-for-gestational-age babiesAndraweera, P.; Dekker, G.; Thompson, S.; Nowak, R.; Zhang, V.; McCowan, L.; North, R.; Roberts, C.
2013Sex hormone binding globulin, but not testosterone, is associated with the metabolic syndrome in overweight and obese women with polycystic ovary syndromeMoran, L.; Teede, H.; Noakes, M.; Clifton, P.; Norman, R.; Wittert, G.
2012Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subferfilityTang, T.; Lord, J.; Norman, R.; Yasmin, E.; Balen, A.